Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis

Inclusion Criteria: * (1) Comply with the diagnostic criteria for chronic non-atrophic gastritis. * (2) Age between 18 to 65 years. * (3) Voluntarily participate the clinical trials and sign informed consent. Exclusion Criteria: * (1) Subjects with history of gastric surgery. * (2) Patients with complicated and special types of gastritis, peptic ulcer, hemorrhage, cholecystitis, cholelithiasis, dysplasia of gastric mucosa or pathological diagnosis of suspected malignant change. * (3) Patients with atrophy and/or intestinal metaplasia through pathological examination showed;. * (4) Severe primary diseases associated with cardiovascular, cerebrovascular, lung, liver, kidney and hematopoietic system (above grade II of cardiac function; Cr value above the upper limit of normal value), or serious diseases affecting their survival, such as cancer or AIDS; * (5) Patients who have used Chinese and Western medicine to treat chronic non-atrophic gastritis in the last two weeks; * (6) Subjects with psychiatric disorders or a history of alcohol/drug abuse; * (7) Pregnant women, woman who are preparing for pregnancy, lactating women; * (8) Patients who are allergic constitution or allergic to known ingredients of test drugs; * (9) Those who have participated in or are participating in other drug clinical trials in the past 3 months; * (10) The syndrome differentiation is not clear or there are too many and complicated syndromes for the subjects; * (11) Subjects that researchers do not consider appropriate to participate in clinical trials. * (12) Patients with poor compliance are not allowed to participate in this trial. * Those who meet one or more of the above exclusion criteria cannot be included in the clinical trial.